Redmile Group, LLC Stevanato Group S.P.A. Transaction History

Redmile Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.15 - $32.86 $17.2 Million - $22.5 Million	-683,763 Reduced 75.81%	218,169 $7.06 Million
Q1 2023 May 15, 2023	SELL	$17.5 - $25.9 $710,377 - $1.05 Million	-40,593 Reduced 4.31%	901,932 $23.4 Million
Q4 2022 Feb 14, 2023	SELL	$13.95 - $19.28 $59,985 - $82,904	-4,300 Reduced 0.45%	942,525 $16.9 Million
Q3 2022 Nov 14, 2022	SELL	$14.66 - $18.3 $2.48 Million - $3.09 Million	-169,000 Reduced 15.15%	946,825 $16 Million
Q2 2022 Aug 15, 2022	SELL	$14.1 - $20.26 $485,040 - $696,944	-34,400 Reduced 2.99%	1,115,825 $17.6 Million
Q1 2022 May 16, 2022	SELL	$15.23 - $21.47 $304,600 - $429,400	-20,000 Reduced 1.71%	1,150,225 $23.1 Million
Q4 2021 Feb 14, 2022	SELL	$21.65 - $27.0 $363,720 - $453,600	-16,800 Reduced 1.42%	1,170,225 $26.3 Million
Q3 2021 Nov 15, 2021	BUY	$19.51 - $28.7 $23.2 Million - $34.1 Million	1,187,025 New	1,187,025 $30 Million

133

54.8M

2.7K

Ticker STVN
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 264,700,000
Market Cap $5.75B
Description
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmile Group, LLC with notifications on news.